Skip to main content

Antiemetic Therapy

0
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Merck & Co.
Merck & Co.RAHWAY, NJ
1 program
non-interventionalN/A3 trials
Active Trials
NCT02888197Completed32Est. Mar 2017
NCT02921035Completed594Est. Jul 2020
NCT01125475Completed61
MSD
MSDIreland - Ballydine
1 program
non-interventionalN/A1 trial
Active Trials
NCT00911222Completed1,035Est. Aug 2009
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
1 program
non-interventionalN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Merck & Co.non-interventional
Merck & Co.non-interventional
Merck & Co.non-interventional
MSDnon-interventional

Clinical Trials (4)

Total enrollment: 1,722 patients across 4 trials

NCT02888197Merck & Co.non-interventional

Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization

Start: Aug 2016Est. completion: Mar 201732 patients
N/ACompleted
NCT02921035Merck & Co.non-interventional

Non-interventional Study to Assess Adherence to Treatment for Patients With RMS (MAIN-MS)

Start: Jun 2016Est. completion: Jul 2020594 patients
N/ACompleted
NCT01125475Merck & Co.non-interventional

A Scandinavian Non-interventional Study of Adherence to RebiSmart Administered Rebif New Formulation (RNF) Treatment in Relapsing Remitting Multiple Sclerosis (RRMS) Subjects

Start: Aug 201061 patients
N/ACompleted
NCT00911222MSDnon-interventional

Epidemiological EMESIS-Registry

Start: Oct 2008Est. completion: Aug 20091,035 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.